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Abstract
In eukaryotes, pre-messenger RNA (pre-mRNA) splicing is an essential process in
gene expression. Splicing is carried out by a dynamic multi-megadalton RNA-protein
complex known as the spliceosome. Sequential transesterification reactions catalyzed
by the spliceosome convert pre-mRNA to mRNA by removing the intervening
sequences (introns) and joining the coding sequences (exons) together. Small nuclear
RNAs (snRNAs) are essential splicing factors. Biallelic mutations of the human
RNU4ATAC gene, which codes for U4atac snRNA, have been identified in patients
diagnosed with Microcephalic Osteodysplastic Primordial Dwarfism type I (MOPD I).
MOPD I is an autosomal recessive disorder characterized by extreme intrauterine
growth retardation, multiple organ abnormalities, and typically early death. The
mutations that have been studied biochemically reduce U4atac snRNA function and
impair minor class (U12-dependent) intron splicing. Four novel patient mutations, 37
G>A, 46 G>A, 48 G>A and 118 T>C, have recently been discovered. To evaluate the
functional effects of these newly discovered mutations on U12-dependent splicing, we
incorporated each of these mutations into a modified human RNU4ATAC gene
construct by site directed mutagenesis. Following verification of the mutations by DNA
sequencing, we prepared DNA for use in an in vivo splicing assay that is based on
genetic suppression. These mutations are expected to affect the binding of proteins to
U4atac snRNA that are important in formation of the catalytically active form of the
spliceosome. We do not yet know how the consequent defective U12-dependent
splicing affects gene expression and yields the MOPD I disease pathologies, but this
study allows us to better understand the mechanistic basis of MOPD I and will serve
as an important foundation for further studies and possible therapeutic intervention in
the future.

